Completed NA INTERVENTIONAL 2-arm NCT01631838

Effects of Tocotrienols Supplementation on Platelet Aggregation in Subjects With Metabolic Syndrome

Sponsor: Malaysia Palm Oil Board

Conditions Metabolic Syndrome Platelet Aggregation, Spontaneous

Interventions Placebo Tocotrienol-rich fraction 400mg

Updated 6 times since 2017 Last updated: Dec 19, 2013 Started: May 31, 2012 Primary completion: Aug 31, 2012 Completion: Oct 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Metabolic Syndrome and Platelet Aggregation, Spontaneous and is currently completed. Malaysia Palm Oil Board leads this study, which shows 6 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Malaysia Palm Oil Board
Universiti Putra Malaysia

Data source: Malaysia Palm Oil Board

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kajang, Malaysia